Skip to content

Member

Ville NIINISTÖ

Greens · Finland

Group
Greens Verts/ALE
Country
Finland
Roll-call participation
74.0 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
99.2 %ⓘ of 4 388 votes where the group had a line · Greens median 97.1 %
More facts (5)
National party
VIHR Vihreä liitto
In office
Since 16 Jul 2024
Against clear line
13 of 4 290 votesⓘ
Committees
AFET (substitute), ITRE, SEDE (substitute)
Member id
197802
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

74.0 %

4 389 of 5 928 roll calls while in office

Greens median: 92.2 % (−18.1 pts)

Chamber median: 90.2 %

With majority line ⓘ

99.2 %

4 354 of 4 388 votes where their group had a line

Greens median: 97.1 % (+2.1 pts)

Against clear line ⓘ

0.3 %

13 of 4 290 votes where their group had a clear line

7 opposite (for ↔ against), 4 abstained against the line, 2 voted for or against when the line was to abstain

Abstention ⓘ

4.6 %

201 of 4 389 votes cast

Participation 74.0 % — Greens median 92.2 %, 54 members.ⓘ
Data as a table
Participation among the 54 members of the Greens with enough votes.
FigureParticipation
Ville NIINISTÖ74.0 %
Greens median92.2 %
Lowest in the group48.0 %
Highest in the group99.6 %
Members54
With majority line 99.2 % — Greens median 97.1 %, 54 members.ⓘ
Data as a table
With majority line among the 54 members of the Greens with enough votes.
FigureWith majority line
Ville NIINISTÖ99.2 %
Greens median97.1 %
Lowest in the group87.9 %
Highest in the group99.4 %
Members54
  • Whole term, 5 928 roll-call votes. The dots are the other members of Greens; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 5 928

Export

Every roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecision and voteResultPositionMajority line
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Final vote — text as a wholeAdopted 434 for, 49 against, 168 abstainedPosition: For Majority line: For
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement (Resolution) Amendment 12, adding text after paragraph 12 72 for, 522 against, 51 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Kyrgyz Republic Enhanced Partnership and Cooperation Agreement Final vote on the draft Council decisionConsent given 473 for, 114 against, 58 abstainedPosition: Against Majority line: Against
9 Sept 2025EU-Brazil Agreement: cooperation with and through Europol and the Federal Police of Brazil Final vote on the draft Council decisionConsent given 606 for, 5 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Final votePassed 431 for, 145 against, 76 abstainedPosition: Abstained Majority line: Abstained
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 395 to recital 19 187 for, 442 against, 16 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 409 + 417 (voted as one) to Annex VII, Part C, point 16 208 for, 431 against, 7 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 371 to Annex VII, Part C, point 13 530 for, 112 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 408 + 416 (voted as one) to Annex VII, Part C, point 6 204 for, 438 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 407 to Annex VII, Part C, point 4 137 for, 447 against, 61 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 318 to Article 55, après le paragraph 2 512 for, 120 against, 14 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 390 to Article 55, après le paragraph 2 105 for, 538 against, 3 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 389 to Article 38, paragraph 3, après le point b 96 for, 549 against, 3 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 388 to Article 18, paragraph 1 124 for, 515 against, 7 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 387 to Article 7, après le paragraph 4 207 for, 431 against, 10 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 2 451 for, 182 against, 10 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 137 to Article 6, paragraph 3, alinéa 1 — part 1 461 for, 185 against, 5 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 394 to Article 6, paragraph 1, après l'alinéa 2 142 for, 496 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 403 to Article 6, paragraph 1, alinéa 2 192 for, 442 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 130 to Article 6, paragraph 1, alinéa 1 444 for, 189 against, 14 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 402 to Article 6, paragraph 1, alinéa 1 194 for, 434 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 393 to Article 6, paragraph 1, alinéa 1 120 for, 529 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 2 438 for, 196 against, 8 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 150 to Article 6 — part 1 452 for, 195 against, 2 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 134 to Article 6 473 for, 154 against, 22 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 2 512 for, 122 against, 15 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 133 to Article 6 — part 1 505 for, 126 against, 19 abstainedPosition: For Majority line: For
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 401 to Article 6 131 for, 447 against, 72 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 392 to Article 4, après le paragraph 1 138 for, 504 against, 4 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 391 to Article 4, paragraph 1, après le point b 138 for, 508 against, 2 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendments 399 + 412 (voted as one) to Article 3, paragraph 1, point 15 168 for, 445 against, 36 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 398 to Article 3, paragraph 1, après le point 9 199 for, 437 against, 11 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 397 to Article 3, paragraph 1, point 9 158 for, 471 against, 17 abstainedPosition: Against Majority line: Against
9 Sept 2025Circularity requirements for vehicle design and management of end-of-life vehicles Amendment 396 to Article 2, paragraph 6, partie introductive 197 for, 418 against, 30 abstainedPosition: Against Majority line: Against
8 Sept 2025Wednesday’s agenda – Request by the PPE Group Ordre du jour de mercredi — Demande du groupe PPE 384 for, 10 against, 51 abstainedPosition: No vote recorded Majority line: Abstained
10 Jul 2025Tackling China’s critical raw materials export restrictions Final vote — text as a wholeAdopted 523 for, 75 against, 14 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 1 to paragraph 14 157 for, 428 against, 36 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 8, adding text after paragraph 13 95 for, 420 against, 119 abstainedPosition: Against Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Paragraph 13 — part 2 483 for, 84 against, 67 abstainedPosition: For Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 7 to paragraph 13 80 for, 407 against, 151 abstainedPosition: Against Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 6, adding text after paragraph 12 79 for, 531 against, 18 abstainedPosition: Against Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 5 to paragraph 10 47 for, 560 against, 27 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 4 to paragraph 8 88 for, 520 against, 22 abstainedPosition: Against Majority line: For
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 3, adding text after paragraph 2 63 for, 552 against, 15 abstainedPosition: Against Majority line: Against
10 Jul 2025Tackling China’s critical raw materials export restrictions Amendment 2, adding text after paragraph 1 123 for, 390 against, 110 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Final vote — text as a wholeAdopted 494 for, 83 against, 71 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 2, adding text after recital S 217 for, 409 against, 23 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Amendment 1, adding text after citation 2 226 for, 409 against, 17 abstainedPosition: Against Majority line: Against
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 34 — part 2 566 for, 60 against, 23 abstainedPosition: For Majority line: For
10 Jul 2025Future of the EU biotechnology and biomanufacturing sector: leveraging research, boosting innovation and enhancing competitiveness Paragraph 32 — part 1 588 for, 56 against, 7 abstainedPosition: For Majority line: For

Show all 50 votes on this page

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 41 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202420
18 Sept 202422
19 Sept 20249291
7 Oct 202420
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202420
22 Oct 20241010
23 Oct 2024129128
24 Oct 20241313
13 Nov 202422
14 Nov 20243636
25 Nov 202420
26 Nov 20241818
27 Nov 20241111
28 Nov 20245757
17 Dec 2024130
18 Dec 2024330
19 Dec 2024450
20 Jan 202520
21 Jan 202511
22 Jan 202522
23 Jan 20254545
10 Feb 202510
11 Feb 20253232
12 Feb 20251010
13 Feb 20253030
10 Mar 202520
11 Mar 202598
12 Mar 2025228226
13 Mar 20252424
31 Mar 202530
1 Apr 20253535
2 Apr 2025251250
3 Apr 20256261
5 May 202550
6 May 2025100
7 May 2025220218
8 May 2025103103
21 May 202522
22 May 20255353
16 Jun 202520
17 Jun 20254141
18 Jun 20259191
19 Jun 20258786
7 Jul 202510
8 Jul 20255555
9 Jul 2025134133
10 Jul 20253636
8 Sept 202510
9 Sept 202510199
10 Sept 20253434
11 Sept 20256969
6 Oct 202520
7 Oct 202555
8 Oct 20255553
9 Oct 2025650
20 Oct 202530
21 Oct 20251313
22 Oct 2025186182
23 Oct 20255555
13 Nov 20252670
24 Nov 202530
25 Nov 20257575
26 Nov 202510098
27 Nov 2025125120
15 Dec 202540
16 Dec 20256665
17 Dec 20254343
18 Dec 2025420
20 Jan 20266767
21 Jan 2026112112
22 Jan 20265857
9 Feb 202620
10 Feb 2026380
11 Feb 2026130
12 Feb 20261410
24 Feb 20264343
9 Mar 202610
10 Mar 2026197197
11 Mar 20266060
12 Mar 20263412
25 Mar 202633
26 Mar 2026690
27 Apr 202620
28 Apr 2026225225
29 Apr 2026296296
30 Apr 20266868
18 May 202640
19 May 202633
20 May 20269695
21 May 2026980
15 Jun 202620
16 Jun 2026400
17 Jun 20261270
18 Jun 2026770
6 Jul 202620
7 Jul 20267272
8 Jul 2026144144
9 Jul 20266767
14 Sept 202610
15 Sept 20261550
16 Sept 2026800
17 Sept 20261240

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within Greens

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Maria OHISALO GreensFinland99 % of 3 609 shared94 %
Bas EICKHOUT Former memberGreensNetherlands99 % of 3 931 shared94 %
Sara MATTHIEU GreensBelgium98 % of 3 687 shared94 %
Terry REINTKE GreensGermany98 % of 4 012 shared94 %
Erik MARQUARDT GreensGermany98 % of 4 149 shared94 %
Rasmus NORDQVIST GreensDenmark98 % of 4 373 shared94 %
Anna CAVAZZINI GreensGermany98 % of 4 337 shared94 %
Hannah NEUMANN GreensGermany98 % of 4 205 shared94 %
Daniel FREUND GreensGermany98 % of 4 349 shared94 %
Katrin LANGENSIEPEN GreensGermany98 % of 4 152 shared94 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Aurore LALUCQ S&DFrance88 % of 3 529 shared83 %
Raphaël GLUCKSMANN S&DFrance87 % of 3 964 shared83 %
Mohammed CHAHIM S&DNetherlands87 % of 3 697 shared83 %
Murielle LAURENT S&DFrance87 % of 3 930 shared83 %
Thijs REUTEN S&DNetherlands86 % of 4 291 shared83 %
Thomas PELLERIN-CARLIN S&DFrance86 % of 4 244 shared83 %
Christophe CLERGEAU S&DFrance86 % of 3 779 shared83 %
Nora MEBAREK S&DFrance86 % of 3 923 shared83 %
Emma RAFOWICZ S&DFrance86 % of 3 332 shared83 %
Eric SARGIACOMO S&DFrance86 % of 4 014 shared83 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on Foreign AffairsAFET CommitteeSubstitute19 Jul 2024now
Committee on Industry, Research and EnergyITRE CommitteeMember19 Jul 2024now
Committee on Security and DefenceSEDE CommitteeSubstitute23 Jan 2025now
Delegation to the EU-UK Parliamentary Partnership AssemblyD-UK Joint parliamentary committeeSubstitute6 Mar 2025now
Delegation to the EU-Russia Parliamentary Cooperation CommitteeD-RU DelegationChair3 Oct 2024now
Delegation for relations with the NATO Parliamentary AssemblyDNAT Parliamentary assemblySubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Intergroup on Anti-Racism and DiversityIG10-02 Intergroup / working groupMember14 Feb 2025now
Intergroup on Children’s RightsIG10-06 Intergroup / working groupMember19 Feb 2025now
Intergroup on DisabilityIG10-10 Intergroup / working groupMember11 Mar 2025now

Show all 17 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
Conclusion, on behalf of the Union, of the Agreement in respect of Gibraltar between the European Union and the European Atomic Energy Community, of the one part, and the United Kingdom of Great Britain and Northern Ireland, of the other partShadow rapporteurAFET13 Jul 2026
Recommendation for the Council, for the Commission and for the Vice-President of the Commission / High Representative of the Union for Foreign Affairs and Security Policy on the changing geopolitical situation in East Asia and the need for closer cooperation with like-minded partners in the regionShadow rapporteurAFET14 Apr 2026
Agreement between the European Union, of the one part, and the Republic of Korea, of the other part, on the participation of the Republic of Korea in Union programmesShadow rapporteurAFET14 Apr 2026
On the adoption of the Research Programme of the Research Fund for Coal and Steel, on the multiannual technical guidelines for this programme, on the multiannual financial guidelines for managing the assets of the Research Fund for Coal and Steel, and repealing Decisions 2003/77/EC and 2008/376/ECShadow rapporteurITRE13 Apr 2026
Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act)Shadow rapporteurITRE26 Mar 2026
No dossier namedShadow rapporteur for an opinionSEDE29 Jan 2026
Establishing Horizon Europe, the Framework Programme for Research and Innovation, for the period 2028-2034 laying down its rules for participation and dissemination, and repealing Regulation (EU) 2021/695Shadow rapporteur for an opinionSEDE29 Jan 2026
No dossier namedShadow rapporteurAFET29 Jan 2026
Establishing the European Fund for economic, social and territorial cohesion, agriculture and rural, fisheries and maritime, prosperity and security for the period 2028-2034Shadow rapporteur for an opinionITRE15 Jan 2026
Establishing a budget expenditure tracking and performance framework and other horizontal rules for the Union programmes and activitiesShadow rapporteur for an opinionITRE15 Jan 2026

Show all 24 dossier roles

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

31 contributions recorded; 10 on behalf of their group; 46 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
29 Apr 2026Danger of normalising relations with Russia, including its participation in major cultural and sports events (debate) Speech · 1 minRead
29 Apr 2026Danger of normalising relations with Russia, including its participation in major cultural and sports events (debate) Speech · 1 minRead
25 Mar 2026Energy security, independence and supply in the geopolitical context - ensuring market stability and affordable energy for industry and citizens (debate) Speech · 1 minRead
10 Mar 2026Recommendation on enhanced EU-Canada cooperation in the current geopolitical context, including the threats to Canada’s economic stability and sovereignty (debate) on behalf of GreensSpeech · 1 minRead
10 Mar 2026Presentation of the Energy Package (debate) Speech · 1 minRead
24 Feb 2026Four years of Russia's war of aggression against Ukraine and European contributions to a just peace and sustained security for Ukraine (debate) Speech · 1 minRead
16 Dec 2025Phasing out Russian natural gas imports and improving monitoring of potential energy dependencies (debate) Speech · 2 minRead
16 Dec 2025Phasing out Russian natural gas imports and improving monitoring of potential energy dependencies (debate) Speech · 4 minRead
26 Nov 2025Implementation of the EU-UK Trade and Cooperation Agreement (debate) Speech · 2 minRead
26 Nov 2025EU position on the proposed plan and EU engagement towards a just and lasting peace for Ukraine (debate) Speech · 2 minRead

Show all 31 recent contributions

Questions and motions, 107

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
10 Sept 2026EU exports of banned pesticides E-10-2026-003605Written questionwith 35 co-authorsNot yet answered
6 Jul 2026MOTION FOR A RESOLUTION on the Threat of War Crimes, the escalating violations of international humanitarian Law and the human rights situation in El-Obeid, Sudan B-10-2026-0358Motion for a resolutionwith 6 co-authors—
1 Jul 2026PROPOSAL FOR A DECISION requesting the Authority for European Political Parties and European Political Foundations to verify whether Europe of Sovereign Nations Party complies with the conditions laid down in Article 3(1), points (d) and (e), of Regulation (EU, Euratom) 2025/2445 B-10-2026-0338Motion for a resolutionwith 246 co-authors—
16 Jun 2026MOTION FOR A RESOLUTION The deteriorating situation of political prisoners in Belarus, in particular the case of Aliaksandra Pulinovich B-10-2026-0324Motion for a resolutionwith 6 co-authors—
15 Jun 2026MOTION FOR A RESOLUTION Political prisoners in Nicaragua – the cases of Carlos Brenes, Salvadora del Socorro Martínez Aburto and Brooklyn Rivera B-10-2026-0293Motion for a resolutionwith 6 co-authors—
15 Jun 2026MOTION FOR A RESOLUTION on Russia’s unacceptable provocative actions and drone incursions into Romania, the Baltic states and Finland B-10-2026-0307Motion for a resolutionwith 6 co-authors—
4 Jun 2026Revision of Regulation (EC) No 1099/2009 and phase-out of CO₂ stunning of pigs E-10-2026-002317Written questionwith 12 co-authors21 Aug 2026
18 May 2026MOTION FOR A RESOLUTION Indonesia : the cases of human rights and environmental defenders Andrie Yunus and Muhammad Rosidi B-10-2026-0248Motion for a resolutionwith 5 co-authors—
12 May 2026Stakeholder involvement and evidence-based decision-making regarding the Fur Free Europe citizens’ initiative E-10-2026-001966Written questionwith 11 co-authors9 Jul 2026
30 Apr 2026Compliance of the Sokli mining project with EU environmental law in the context of potential strategic project status under the Critical Raw Materials Act E-10-2026-001779Written questionwith 1 co-author1 Jul 2026

Show all 107 questions and motions

Amendments tabled in committee, 43

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
17 Sept 2026Mobile satellite services: selection and authorisation of systems using the harmonised 2 GHz frequency band ITRE-AM-792052 ITRE2
17 Sept 2026Mobile satellite services: selection and authorisation of systems using the harmonised 2 GHz frequency band ITRE-AM-792193 ITRE1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ5321
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ5313
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790932 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790935 CJ5322
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790953 CJ5314
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790005 CJ5312
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ5320

Show all 43 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Finland National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
1 October 2026

Cite as

EU Parl Watch Research (2026). “Ville NIINISTÖ”. Member record. memberId 197802. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/197802?page=77&vscope=all (retrieved 1 October 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/197802. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/197802?format=application%2Fld%2Bjson (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-197802,
  author = {{EU Parl Watch Research}},
  title = {{Ville NIINISTÖ}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/197802?page=77&vscope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/197802?page=77&vscope=all},
  urldate = {2026-10-01},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 197802. Official source: https://www.europarl.europa.eu/meps/en/197802. Data: EP Open Data: member record (CC BY 4.0); data version 7669c786bb14 (1 Oct 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}